AI assistant
NeuroPace Inc — Director's Dealing 2021
Apr 20, 2021
33194_dirs_2021-04-20_2e04d608-f50a-4368-a3b8-0330f03bcfc6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NeuroPace Inc (NPCE)
CIK: 0001528287
Period of Report: 2021-04-20
Reporting Person: Kuhn Rebecca (Chief Financial Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3226 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $0.03 | 2030-10-29 | Common Stock (196153) | Direct | |
| Stock Option (Right to Buy) | $0.03 | 2020-11-12 | Common Stock (10634) | Direct | |
| Stock Option (Right to Buy) | $0.03 | 2022-11-12 | Common Stock (692) | Direct | |
| Stock Option (Right to Buy) | $0.03 | 2025-02-05 | Common Stock (482) | Direct | |
| Stock Option (Right to Buy) | $0.03 | 2024-02-10 | Common Stock (254) | Direct |
Footnotes
F1: 1/48th of the shares subject to the option vest in equal monthly installments commencing September 19, 2020.
F2: 25% of the shares subject to the option vest on Janaury 1, 2018; 1/48th of the shares subject to the option vest in 36 equal monthly installments thereafter.
F3: The share underlying the option are fully vested.
F4: 1/48th of the shares subject to the option vest in equal monthly installments commencing December 11, 2014.
F5: 1/48th of the shares subject to the option vest in equal monthly installments commencing September 23, 2014.